Table 1.
Characteristics of 109 patients with C1-INH-HAE and 68 healthy donor controls.
| Characteristics | Healthy donors (n = 68) | Patients (n = 109) |
|---|---|---|
| Age—yearsa | 32 (28–40) | 37 (23–48) |
| Gender male—no. (%) | 32 (47%) | 38 (34.9%) |
| Caucasian race—% | 100% | 100% |
| Unrelated families | NA | 76 |
| Age at onset—yearsa | NA | 6 (3–14) |
| C1-INH-HAE—no. (%) | ||
| Type I | NA | 104 (95.4%) |
| Type II | NA | 5 (4.5%) |
| Prophylaxis—no. (%) | ||
| Tranexamic acid | NA | 4 (3.8%) |
| Attenuated androgens | NA | 15 (10%) |
| ≥12 attacks/year—no. (%) | NA | 40 (36.7%) |
aData are expressed as median values (interquartile ranges). Data were analyzed by t-test.
NA, not applicable.